Trial Profile
Safety and efficacy of vedolizumab in patients with irritable bowel syndrome: A real-world experience
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Feb 2016
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Irritable bowel syndrome
- Focus Adverse reactions; Therapeutic Use
- 24 Feb 2016 New trial record